Answers are grounded in this paper and cite their sources.
Mitochondrial reactive oxygen species (mROS) and increased Ca 2+ influx mediated by transient receptor potential (TRP) melastatin 2 (TRPM2) channel activation have been closely linked to neurodegenerative disorders. While antioxidants, 2‐aminoethoxydiphenyl borate (2APB), and N‐(p‐amylcinnamoyl)anthranilic acid (ACA) suppress TRPM2, oxidative stress and ADP‐ribose (ADPR) activate it. The most specific non‐steroidal anti‐inflammatory medications that have antioxidant properties are diclofenac (DIF) and ibuprofen (IBU). Arachidonic acid (ARA) has been shown to stimulate Ca 2+ in neuronal cells by TRP vanilloid 4 (TRPV4) and TRP ankyrin 1 (TRPA1) activations, but not TRPM2 stimulation. By blocking TRPM2, we evaluated the protective effects of DIF and IBU on ARA‐induced oxidative neurotoxicity in human SH‐SY5Y neuronal cells. Eight groups as control, DIF, IBU, ACA, ARA, ARA + DIF, ARA + IBU, and ARA + ACA were induced in the SH‐SY5Y cells. ARA exposure and TRPM2 agonist (ADPR and H 2 O 2 )‐induced TRPM2 currents and Ca 2+ influx were downregulated by the treatments of ACA, 2APB, IBU, DIF, and PLA2 inhibitor (bromoenol lactone). The treatments also reduced the ARA‐induced increases of lipid peroxidation, apoptosis, mitochondrial membrane dysfunction, mROS, intracellular ROS, Zn 2+ , Fe 2+ , cell death, and caspase values by increasing cell viability, glutathione (GSH), and glutathione peroxidase (GSH‐Px). In conclusion, IBU and DIF treatments modify ARA‐mediated increases in mROS, apoptosis, oxidative damage, Fe 2+ , Zn 2+ , and Ca 2+ influx by TRPM2 inhibition but GSH level/GSH‐Px activation. The results of the novel TRPM2 antagonists (IBU and DIF) may offer protection against the mROS neuronal damage caused by the novel TRPM2 agonist (ARA), which is linked to increased apoptosis.
No takes yet. Share an insight, caveat, or question.
Güzel et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: